A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin

Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choi...

Descripción completa

Detalles Bibliográficos
Autores principales: Meconi, Federico, Provenzano, Ida, Nasso, Daniela, Mariotti, Benedetta, Pupo, Livio, Secchi, Roberto, Cerretti, Raffaella, Lucia, Anemona, Arcese, William, Cantonetti, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455409/
https://www.ncbi.nlm.nih.gov/pubmed/32884752
http://dx.doi.org/10.1002/ccr3.2898
_version_ 1783575618570420224
author Meconi, Federico
Provenzano, Ida
Nasso, Daniela
Mariotti, Benedetta
Pupo, Livio
Secchi, Roberto
Cerretti, Raffaella
Lucia, Anemona
Arcese, William
Cantonetti, Maria
author_facet Meconi, Federico
Provenzano, Ida
Nasso, Daniela
Mariotti, Benedetta
Pupo, Livio
Secchi, Roberto
Cerretti, Raffaella
Lucia, Anemona
Arcese, William
Cantonetti, Maria
author_sort Meconi, Federico
collection PubMed
description Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL.
format Online
Article
Text
id pubmed-7455409
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74554092020-09-02 A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin Meconi, Federico Provenzano, Ida Nasso, Daniela Mariotti, Benedetta Pupo, Livio Secchi, Roberto Cerretti, Raffaella Lucia, Anemona Arcese, William Cantonetti, Maria Clin Case Rep Case Reports Occasionally, non‐Hodgkin lymphomas (NHL) occur simultaneously or subsequently to Hodgkin disease. We report on a case of a woman with Hodgkin lymphoma treated with ABVD, who developed 4 years later T‐cell NHL with both nodal and extranodal involvement. Brentuximab vedotin could be an effective choice in treating metachronous T‐cell NHL. John Wiley and Sons Inc. 2020-05-05 /pmc/articles/PMC7455409/ /pubmed/32884752 http://dx.doi.org/10.1002/ccr3.2898 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Meconi, Federico
Provenzano, Ida
Nasso, Daniela
Mariotti, Benedetta
Pupo, Livio
Secchi, Roberto
Cerretti, Raffaella
Lucia, Anemona
Arcese, William
Cantonetti, Maria
A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title_full A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title_fullStr A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title_full_unstemmed A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title_short A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
title_sort case of metachronous peripheral t‐cell non‐hodgkin lymphoma following chemotherapy for hodgkin disease successfully treated with brentuximab vedotin
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455409/
https://www.ncbi.nlm.nih.gov/pubmed/32884752
http://dx.doi.org/10.1002/ccr3.2898
work_keys_str_mv AT meconifederico acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT provenzanoida acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT nassodaniela acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT mariottibenedetta acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT pupolivio acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT secchiroberto acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT cerrettiraffaella acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT luciaanemona acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT arcesewilliam acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT cantonettimaria acaseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT meconifederico caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT provenzanoida caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT nassodaniela caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT mariottibenedetta caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT pupolivio caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT secchiroberto caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT cerrettiraffaella caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT luciaanemona caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT arcesewilliam caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin
AT cantonettimaria caseofmetachronousperipheraltcellnonhodgkinlymphomafollowingchemotherapyforhodgkindiseasesuccessfullytreatedwithbrentuximabvedotin

Ejemplares similares